Pharmaceutical Technology

MAY 3, 2023

Since 2015, the US Food and Drug Administration (FDA) has approved more than 450 “first generics” or the first generic equivalent for a branded drug. These medicines comprise about 10% of all generics approved each year.

Generic Drugs 246

Generic Drugs Drugs Medicine FDA Approval 246

World of DTC Marketing

JANUARY 28, 2022

The Department of Health and Human Services is currently considering whether to allow the generic manufacturing of Xtandi, which could drop the price of a pill from $400 to $3 overnight. When drug makers like Xtandi’s manufacturer, Astellas Pharma, price gouge sick Americans, the U.S. The post Drug company profiteering.

Drugs 284

Drugs Generic Drugs Manufacturing Licensing 284

BioSpace

JANUARY 14, 2021

Billionaire entrepreneur Mark Cuban, best known as the owner of the Dallas Mavericks and an investor on the ABC business reality series “Shark Tank,” is diving into generic drugs with a new startup, dubbed Mark Cuban Cost Plus Drug Company.

Generic Drugs 99

Generic Drugs Drugs Marketing 99

Scienmag

JUNE 20, 2022

billion by purchasing generic drugs at Mark Cuban prices Abstract: [link] URL goes live when the embargo lifts A brief research report found that Medicare could have saved up to $3.6 billion by purchasing generic drugs at the same prices as the Mark Cuban Cost Plus Drug […]. Medicare could save up to $3.6

Generic Drugs 67

Generic Drugs Drugs Research 67

Drug Channels

JUNE 22, 2022

In the video below, I discuss how generic drug pricing and the rise of patient-paid, discount card prescriptions pose a risk to pharmacy benefit plans and the PBM business. d/b/a Drug Channels Institute. Drug Channels® is a registered trademark of Pembroke Consulting, Inc.

Generic Drugs 72

Generic Drugs Drugs Pharmacy 72

STAT News

MARCH 10, 2023

Revelations that AbbVie, the manufacturer of Humira, made more than $100 billion in extra profits by abusing the patent system to delay generic competition has spurred efforts by the Biden administration and Congress to limit the length of patent monopolies over prescription drugs. Read the rest…

Generic Drugs 98

Generic Drugs Drugs Manufacturing 98

The Pharma Data

MAY 5, 2021

FDA officials said that the number of a product specific guidances (PSGs) issued by the Office of Generic Drugs (OGD) has increased steadily since FY 2013. FDA webinar on product specific guidance for generic drugs . In FY 2019, 252 were issued, as were 208 in FY 2018. . Source link.

Generic Drugs 52

Generic Drugs Drugs Development Research 52

Drug Patent Watch

AUGUST 12, 2020

Just because a drug has received FDA approval does not mean that it is available in the marketplace. The post Generic Drugs Approved but not Launched – How to Tell When Generic Drugs Will hit the Market appeared first on DrugPatentWatch - Make Better Decisions.

Generic Drugs 52

Generic Drugs Drugs FDA Approval Marketing 52

Pharmaceutical Technology

JULY 25, 2022

Specialty generics is a term used to refer to generic versions of drugs that are often expensive, complex, or “high touch”—requiring significant involvement of service to manage. Specialty drugs are most used to treat different cancers, rheumatoid arthritis, and multiple sclerosis. But there are some exceptions.

Drugs 298

Drugs Pharmacy Bioequivalency Manufacturing 298

Pharmaceutical Technology

APRIL 4, 2023

Indian pharma manufacturing continues to be the backbone of drug supplies worldwide, and GlobalData analysis suggests US overreliance on the country for generic drug supply. Source: GlobalData, Pharma Intelligence Center Drug Database (Accessed March 20, 2023). © GlobalData. ©GlobalData.

Manufacturing 130

Manufacturing Generic Drugs Gene Therapy Contract Manufacturing 130

Drug Patent Watch

SEPTEMBER 15, 2020

This likely means fewer generic entrants and less opportunities for consumers to enjoy…. The post Bloomberg and Drug PatentWatch: A “Perfect Storm” Affecting Generic Drugs appeared first on DrugPatentWatch - Make Better Decisions.

Generic Drugs 52

Generic Drugs Drugs 52

Pharmaceutical Technology

SEPTEMBER 15, 2022

BioNTech has shifted its focus towards oncology, with the company expecting the first results from a Phase II trial of its first-in-class CAR-T drug, BNT211, for multiple solid tumours. However, other challenges facing biopharmaceutical companies include growing generic drug competition, which places pressure on drug prices.

Vaccination 272

Vaccination Vaccine Generic Drugs Drugs 272

STAT News

FEBRUARY 14, 2023

WASHINGTON — The Biden administration on Tuesday announced three new drug pricing policy experiments that would standardize how much Medicare patients pay for certain generic drugs, pilot new ways for Medicaid to pay for pricey cell and gene therapies, and test ways to pay for drugs approved without proven clinical benefit to patients.

Drugs 98

Drugs Gene Therapy Generic Drugs Gene 98

STAT News

MARCH 7, 2023

… The White House will propose raising taxes on Americans earning more than $400,000 and reducing what Medicare pays for prescription drugs in an attempt to ensure that the health-care program for seniors is funded for the next two decades , STAT writes.  The Continue to STAT+ to read the full story…

Drugs 98

Drugs Generic Drugs Packaging Packaging 98

STAT News

FEBRUARY 9, 2023

WASHINGTON — The Senate Judiciary Committee on Thursday passed legislation to prevent drug companies from gaming the patent system to delay competition from cheaper generics, but members in both parties said they still have concerns about the reforms.

Drugs 98

Drugs Generic Drugs 98

BioSpace

NOVEMBER 29, 2020

For the medical industry, China's proposed patent linkage system can be more favorable to generic drug companies than the U.S. The fourth Amendment of the China Patent Law has been deliberated and was passed on October 17, 2020. It will come into force on June 1, 2021.

Generic Drugs 73

Generic Drugs Drugs 73

BioTech 365

MAY 28, 2021

Global Generic Drugs Market Report 2021: The New Generics Era – The Patent Cliff, Types of Generic Drugs, Simple Generics, Super Generics, Biosimilars, ANDA Approvals – ResearchAndMarkets.com Global Generic Drugs Market Report 2021: The New Generics Era – The Patent … Continue reading →

Generic Drugs 40

Generic Drugs Drugs Marketing 40

BioTech 365

OCTOBER 1, 2021

Regarding Generic Drugs Sandoz Resolves Legacy Federal Government Civil Investigation in the U.S. Regarding Generic Drugs Company previously disclosed settlement agreement in principle and fully provisioned for this resolution Basel, … Continue reading →

Generic Drugs 40

Generic Drugs Drugs 40

BioTech 365

JUNE 25, 2021

GCC Generic Drug Market Trends, Share, Size, Opportunity and Forecasts 2021-2026 – ResearchAndMarkets.com GCC Generic Drug Market Trends, Share, Size, Opportunity and Forecasts 2021-2026 – ResearchAndMarkets.com DUBLIN–(BUSINESS WIRE)–The “GCC Generic Drug Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast (..)

Generic Drugs 40

Generic Drugs Drugs Marketing 40

BioTech 365

OCTOBER 4, 2021

Canada Generic Drug Market Industry Trends, Share, Size, Growth, Opportunity and Forecasts 2021-2026 – ResearchAndMarkets.com Canada Generic Drug Market Industry Trends, Share, Size, Growth, Opportunity and Forecasts 2021-2026 – ResearchAndMarkets.com DUBLIN–(BUSINESS WIRE)–The “Canada Generic Drug Market: Industry Trends, (..)

Generic Drugs 40

Generic Drugs Drugs Marketing 40

NY Times

SEPTEMBER 18, 2021

Competition for market share at rock-bottom prices has led to shortages, price-spikes, allegations of price-fixing, and substandard and even dangerous practices.

Generic Drugs 96

Generic Drugs Drugs Marketing Manufacturing 96

Drug Channels

OCTOBER 18, 2022

The biosimilar boom for provider-administered drugs continues to accelerate. Below, we share our estimates for wholesalers’ gross margins for brand-name, generic, and biosimilar drugs. We then explain the channel dynamics behind biosimilar and generic drugs’ profits. drug distribution.

Drugs 71

Drugs Generic Drugs Branding Sales 71

BioTech 365

NOVEMBER 18, 2021

Brazil Generic Drug Market (2021 to 2026) – Industry Trends, Share, Size, Growth, Forecast and Opportunities – ResearchAndMarkets.com Brazil Generic Drug Market (2021 to 2026) – Industry Trends, Share, Size, Growth, Forecast and Opportunities – ResearchAndMarkets.com DUBLIN–(BUSINESS WIRE)–The “Brazil Generic (..)

Generic Drugs 40

Generic Drugs Drugs Marketing 40

Pharmaceutical Technology

MAY 31, 2023

According to GlobalData, Phase I drugs for Solid Tumor have a 54% phase transition success rate (PTSR) indication benchmark for progressing into Phase II. GlobalData’s report assesses how Sym-021’s drug-specific PTSR and Likelihood of Approval (LoA) scores compare to the indication benchmarks. Buy the report here.

Generic Drugs 100

Generic Drugs Clinical Trials Clinical Trials Drugs 100

BioTech 365

APRIL 28, 2021

United States Drug Patent Prices Database 2021: Brand vs. Generic Drug Price Gap, find generic entry opportunities – ResearchAndMarkets.com United States Drug Patent Prices Database 2021: Brand vs. Generic Drug Price Gap, find generic entry opportunities – ResearchAndMarkets.com DUBLIN–(BUSINESS WIRE)–The … Continue reading (..)

Generic Drugs 40

Generic Drugs Drugs Branding 40

Pharmacy Checkers

JULY 11, 2019

I’m proud to share that PharmacyChecker has published a white paper that examines prices and availability of newly approved generic drugs. Our report, based on 40 generic medications that were approved from 2017-2018, clearly shows that generic drug approvals often don’t lead to greater affordability or even access here in the U.S.

Generic Drugs 48

Generic Drugs FDA Approval Drugs Pharmacy 48

Medical Xpress

APRIL 19, 2023

Since the overturning of Roe v. Wade in June 2022 and the end of constitutional protection for abortion, emergency contraception has become more difficult to obtain and—more than ever—shrouded in misinformation.

Generic Drugs 69

Generic Drugs Drugs 69

STAT News

JANUARY 24, 2023

users with a new prescription benefit called RxPass, which will allow Prime members to get as many drugs as they need for $5 a month from a list of 50 generic medications used to treat more than 80 common conditions , CNBC tells us. Amazon We are adding to our list of pen pals all the time.

Generic Drugs 98

Generic Drugs Drugs Pharmacy Branding 98

Pharmaceutical Technology

SEPTEMBER 23, 2022

Avéma, for example, specialises in small molecule, oral solid, and liquid dose drugs. generic drugs at both small development companies and multinational pharmaceutical companies. One of the first things Avéma does with a new project is to evaluate the drug molecule to make sure it's a fit for available facilities.

Drugs 147

Drugs Manufacturing Pharma Companies Generic Pharmaceutical 147

STAT News

AUGUST 3, 2022

In the latest bid to address high prescription drug costs, a nonprofit plans to sell a cheaper generic version of an expensive cancer medicine in the U.S.

Generic Drugs 98

Generic Drugs Drugs Pharmacy Medicine 98

BioTech 365

APRIL 15, 2021

Global Generic Drugs (Small Molecule Generics vs Biosimilars) Market Forecast & Opportunities, 2021-2026 by Application, Drug Delivery, Form, Source, Distribution Channel – ResearchAndMarkets.com Global Generic Drugs (Small Molecule Generics vs Biosimilars) Market Forecast & Opportunities, 2021-2026 by Application, Drug Delivery, … (..)

Generic Drugs 40

Generic Drugs Drug Delivery Drugs Marketing 40

World of DTC Marketing

AUGUST 7, 2022

The passage of the Inflation Control bill is an excellent first step in limiting high drug costs, but our healthcare system is still built for profit at the expense of patients. Once limited to a few new treatments, it’s now being applied widely, even to generic drugs and established regimens.?The The result:? Schumer (D-N.Y.)

Generic Drugs 263

Generic Drugs Doctors Doctor Drugs 263

FDA Law Blog

NOVEMBER 16, 2021

5376 that has garnered the greatest amount of attention (at least in the food and drug law world) is TITLE XIII, Subtitle J (Drug Pricing), Part 1 (Lowering Prices Through Fair Drug Price Negotiation), Section 139001 (Providing for Lower Prices for Certain High-Priced Single Source Drugs). a) In General.—The

Generic Drugs 52

Generic Drugs Drugs Manufacturing Licensing 52

Pharmaceutical Technology

MAY 16, 2023

during Q1 2023 largely due to the advancement of a pair of Phase III trials, Oceanic-AF and Oceanic-Stroke, for their blood-thinning drug, Asundexian. According to GlobalData’s drugs database pharma intelligence centre, Wegovy is expected to generate an analyst consensus global forecast sales of $9.4 Novo Nordisk reported an 18.2%

Generic Drugs 130

Generic Drugs FDA Approval Drugs Marketing 130

STAT News

DECEMBER 13, 2022

WASHINGTON — The Biden administration signaled Monday that it will require health plans on federal exchanges to cover more of the costs of generic drugs, a small tweak that nevertheless has industry groups divided on how best to manage drug costs. Continue to STAT+ to read the full story…

Generic Drugs 98

Generic Drugs Drugs Regulation 98

STAT News

AUGUST 19, 2022

Sun Pharmaceutical, which is one of the largest purveyors of generic drugs, allegedly falsified various documents that were maintained by employees at one of its plants in India, according to an inspection report issued by the U.S. Food and Drug Administration.

Drugs 98

Drugs Generic Drugs Medicine 98

STAT News

MARCH 30, 2023

Are some drugs too cheap? We also discuss what leads to generic drug shortages, whether every major pharmaceutical firm needs a weight-loss drug, and what it means when drug company cancels a conference appearance. What happened to the market for monkeys? And why are biotech stocks still in the tank?

Generic Drugs 105

Generic Drugs Drugs Marketing 105